Bengaluru: AstraZeneca, a global, science-led biopharmaceutical company, announced the expansion of its state-of-the-art Global Hub in Bangalore, strengthening its presence in India. The new facility will house nearly 1300 employees, including 400 new jobs, supporting the company’s capabilities in AI-powered innovation across Research and Development, Global Business Services, IT, and Digital Health operations.
This announcement represents AstraZeneca’s second major investment in India within a year, following the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The combined workforce now at AstraZeneca India Private Limited (AZIPL) will reach close to 4,000 employees, strengthening company’s capability to deliver life-changing medicines to patients worldwide.
“Our Global Hub in Bangalore is a strategic investment that will play a vital role in advancing AstraZeneca’s bold ambition to deliver 20 new medicines by 2030 — by strengthening automated, scalable, data-driven, and patient-centric solutions. This step reflects our commitment to tapping into the world-class talent and ecosystem available in Karnataka to power the next generation of scientific innovation. We are equally committed to decarbonize our operations and value chain, and the hub supports our net zero ambition”, said Jackie Crockford, Vice President, Global Business Services, AstraZeneca.
“This hub enhances our R&D capabilities by connecting us with India’s exceptional scientific and technological expertise. The expansion will accelerate the development of innovative medicines and help us deliver across R&D, ultimately benefitting patients around the world”, said Magnus Nord, Vice President, Global Patient Safety BioPharma, AstraZeneca.
The new facility will serve as a dynamic hub dedicated to advancing AstraZeneca’s critical priorities:
Advanced clinical research supporting AstraZeneca’s global therapeutic areas
Development of AI-powered healthcare solutions and digital health technologies
Centralized data analytics to enhance clinical trial efficiency and patient outcomes
Specialized support for global regulatory compliance and pharmacovigilance
The Karnataka government has welcomed the expansion as a validation of the state’s position as a global innovation hub. “AstraZeneca’s investment reaffirms India’s leadership in science, technology, and healthcare, and is a testament to Karnataka’s robust life sciences ecosystem. This expansion aligns perfectly with our vision to create high-value employment opportunities while fostering innovation in critical sectors, making Bangalore a global hub for biotechnology and R&D,” said Honorable Minister Shri Dinesh Gundu Rao, Ministry of Health & Family Welfare, Government of Karnataka.
The Global Hub in Bangalore reflects AstraZeneca’s dedication to environmental sustainability and every aspect of this facility has been carefully planned to make a meaningful progress towards a healthier planet. The hub is designed to achieve LEED Platinum certification and is currently powered by 75% green energy. It implements full waste-water recycling, IoT-enabled systems for optimized energy management and much more.